PTPRC and systemic lupus erythematosus: Consistent with our studies in the NZBWF1 model, as well as previous studies in pristane‐induced lupus (Lech & Anders, 2013; Summers et al., 2014; Taylor et al., 2018; Taylor & Ryan, 2017), we detected increased CD45+ and CD4+ T cells in the kidney.